![Xiao Hui Ji](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Xiao Hui Ji
Directeur/Bestuurslid bij
LEGEND BIOTECH CORPORATION
Vermogen: 526 184 $ op 31-05-2026
Profiel
Xiao Hui Ji is the founder of Elpiscience Biopharma Ltd., serving as Chairman & Chief Executive Officer since 2017.
Dr. Ji is the founder of Elpiscience Biopharmaceuticals, Inc., serving as Chairman & Chief Executive Officer since 2017.
Dr. Ji was the founder of PharmaLegacy Laboratories (Shanghai) Co., Ltd., serving as Chief Executive Officer from 2008 to 2012.
Dr. Ji is currently an Independent Director at Legend Biotech Corp.
since 2020.
Former positions include Director at The BayHelix Group from 2008 to 2013, Vice President-Business Development at Roche Holding AG from 2013 to 2016, and Partner at LAV Management Co., Ltd. from 2017 to 2020.
Education includes an MBA from The University of Chicago, a doctorate from The University of Sheffield, and a doctorate from China Medical University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
LEGEND BIOTECH CORP. 0,01% | 18-03-2026 | 38.747 ( 0,01% ) | 526 184 $ | 31-05-2026 |
Actieve functies van Xiao Hui Ji
| Bedrijven | Functie | Begin |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Directeur/Bestuurslid | 01-05-2020 |
Elpiscience Biopharma Ltd.
 Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Develops cutting-edge immunotherapies to fight cancer | Algemeen Directeur | 01-06-2017 |
Elpiscience Biopharmaceuticals, Inc.
 Elpiscience Biopharmaceuticals, Inc. BiotechnologyHealth Technology Functions as an investment holding company whose subsidiaries operates clinical-stage biopharmaceutical company that develops immunotherapies for cancer patients | Algemeen Directeur | 01-06-2017 |
Eerdere bekende functies van Xiao Hui Ji
| Bedrijven | Functie | Einde |
|---|---|---|
LAV Management Co., Ltd.
 LAV Management Co., Ltd. Investment ManagersFinance LAV invests in companies located in China and the United States. The firm targets companies operating in the fields of biopharmaceuticals, human therapeutics, medical devices and diagnostics. It provides financing for seed, early and later stage capital requirements. | Corporate Officer/Principal | 01-05-2020 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 01-12-2016 |
The BayHelix Group
 The BayHelix Group Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit professional organization | Directeur/Bestuurslid | 01-01-2013 |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
 PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical research and development company that focuses on preclinical pharmacology & pharmacodynamics evaluation services | Algemeen Directeur | 01-01-2012 |
Opleiding van Xiao Hui Ji
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
21
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Sheffield
 The University of Sheffield Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
China Medical University
 China Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV invests in companies located in China and the United States. The firm targets companies operating in the fields of biopharmaceuticals, human therapeutics, medical devices and diagnostics. It provides financing for seed, early and later stage capital requirements. | Finance |
The BayHelix Group
The BayHelix Group Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit professional organization | Commercial Services |
Legend Biotech Corp.
 Legend Biotech Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which engages in the discovery and development of novel cell therapies for oncology | Health Technology |
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Develops cutting-edge immunotherapies to fight cancer | Health Technology |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical research and development company that focuses on preclinical pharmacology & pharmacodynamics evaluation services | Commercial Services |
Elpiscience Biopharmaceuticals, Inc.
Elpiscience Biopharmaceuticals, Inc. BiotechnologyHealth Technology Functions as an investment holding company whose subsidiaries operates clinical-stage biopharmaceutical company that develops immunotherapies for cancer patients | Health Technology |
